Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A15951 | 28639757 | Rev Med Suisse | [Ketogenic diets : the miraculous solution ?] | 2017 | Details |
A15952 | 28638585 | Middle East J Dig Dis | Clinicopathological Study of Seronegative Celiac Disease in Adults in Pakistan: A Pilot Study. | 2017 | Details |
A15953 | 28638584 | Middle East J Dig Dis | The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population. | 2017 | Details |
A15954 | 28638220 | World J Gastroenterol | Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats. | 2017 | Details |
A15955 | 28637594 | Metabolism | Association of plasma dipeptidyl peptidase-4 activity with non-alcoholic fatty liver disease in nondiabetic Chinese population. | 2017 | Details |
A15956 | 28637520 | Br J Nutr | Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver. | 2017 | Details |
A15957 | 28637446 | BMC Gastroenterol | miR-363-5p as potential prognostic marker for hepatocellular carcinoma indicated by weighted co-expression network analysis of miRNAs and mRNA. | 2017 | Details |
A15958 | 28637408 | Curr Vasc Pharmacol | Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis. | 2018 | Details |
A15959 | 28637104 | Korean J Gastroenterol | [Treatment Options in Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
A15960 | 28637103 | Korean J Gastroenterol | [The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
A15961 | 28637102 | Korean J Gastroenterol | [The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
A15962 | 28637101 | Korean J Gastroenterol | [Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
A15963 | 28636830 | Appl Physiol Nutr Metab | Attenuation of hepatic steatosis by purple sweet potato colour is associated with blocking Src/ERK/C/EBPβ signalling in high-fat-diet-treated mice. | 2017 | Details |
A15964 | 28636211 | Clin Transplant | Resolution of donor non-alcoholic fatty liver disease following liver transplantation. | 2017 | Details |
A15965 | 28635586 | Gene Expr | GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease. | 2017 | Details |
A15966 | 28635324 | Antioxid Redox Signal | Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis. | 2017 | Details |
A15967 | 28635128 | J Biophotonics | Development of a classification model for non-alcoholic steatohepatitis (NASH) using confocal Raman micro-spectroscopy. | 2017 | Details |
A15968 | 28634585 | J Diabetes Res | High Plasma Glucagon Levels Correlate with Waist-to-Hip Ratio, Suprailiac Skinfold Thickness, and Deep Subcutaneous Abdominal and Intraperitoneal Adipose Tissue Depots in Nonobese Asian Indian Males with Type 2 Diabetes in North India. | 2017 | Details |
A15969 | 28634412 | Nat Rev Gastroenterol Hepatol | Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets. | 2017 | Details |
A15970 | 28632778 | PLoS One | Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice. | 2017 | Details |
A15971 | 28632732 | PLoS One | Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis. | 2017 | Details |
A15972 | 28632197 | Nutrients | Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD. | 2017 | Details |
A15973 | 28632181 | Nutrients | Spirulina Protects against Hepatic Inflammation in Aging: An Effect Related to the Modulation of the Gut Microbiota? | 2017 | Details |
A15975 | 28630692 | J Nutr Sci | Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop. | 2017 | Details |
A15976 | 28630632 | Evid Based Complement Alternat Med | Erchen Decoction and Linguizhugan Decoction Ameliorate Hepatic Insulin Resistance by Inhibiting IRS-1Ser307 Phosphorylation In Vivo and In Vitro. | 2017 | Details |
A15977 | 28629152 | Children (Basel) | The Association between Pediatric NAFLD and Common Genetic Variants. | 2017 | Details |
A15978 | 28628909 | J Nutr Biochem | Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E). | 2017 | Details |
A15979 | 28628674 | PLoS One | Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease. | 2017 | Details |
A15980 | 28628263 | Hepatol Res | Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non-alcoholic fatty liver disease. | 2017 | Details |
A15981 | 28628039 | J Clin Invest | ChREBP refines the hepatic response to fructose to protect the liver from injury. | 2017 | Details |
A15982 | 28628033 | J Clin Invest | Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis. | 2017 | Details |
A15983 | 28627263 | Arch Physiol Biochem | Association of interleukin-1A insertion/deletion gene polymorphism and possible high risk factors with non-alcoholic fatty liver disease in Egyptian patients. | 2017 | Details |
A15984 | 28627213 | Nutr Hosp | Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update | 2017 | Details |
A15985 | 28626963 | Exp Physiol | Exercise training modulates the hepatic renin-angiotensin system in fructose-fed rats. | 2017 | Details |
A15986 | 28626169 | Intern Med | New Discriminant Method for Identifying the Aggressive Disease Phenotype of Non-alcoholic Fatty Liver Disease. | 2017 | Details |
A15987 | 28626098 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | [Association between glycosylated hemoglobin and 
non-alcoholic fatty liver disease in 
health examination population]. | 2017 | Details |
A15989 | 28624576 | Gastroenterology | Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis. | 2017 | Details |
A15990 | 28623272 | Sci Rep | Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells. | 2017 | Details |
A15991 | 28623125 | Biochem Biophys Res Commun | Chronic intermittent hypoxia induces liver fibrosis in mice with diet-induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways. | 2017 | Details |
A15992 | 28622441 | Transpl Int | Cardiovascular mortality among liver transplant recipients with nonalcoholic steatohepatitis in the United States-a retrospective study. | 2017 | Details |
A15994 | 28621635 | Exp Clin Transplant | Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant. | 2017 | Details |
A15995 | 28621554 | Expert Rev Gastroenterol Hepatol | Gut microbiota changes and chronic hepatitis C virus infection. | 2017 | Details |
A15996 | 28621339 | Nat Rev Endocrinol | Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. | 2017 | Details |
A15999 | 28620012 | Clin Sci (Lond) | Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes. | 2017 | Details |
A16001 | 28619255 | J Hepatol | Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents. | 2017 | Details |
A16002 | 28618991 | Curr Med Chem | Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions. | 2018 | Details |
A16003 | 28618039 | J Gastroenterol Hepatol | Correlation between serum galectin-9 levels and liver fibrosis. | 2018 | Details |
A16004 | 28616057 | J Res Med Sci | Serum omentin-1, vaspin, and apelin levels and central obesity in patients with nonalcoholic fatty liver disease. | 2017 | Details |
A16005 | 28615690 | Sci Rep | Cathepsin D regulates lipid metabolism in murine steatohepatitis. | 2017 | Details |
A16006 | 28615649 | Sci Rep | Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis. | 2017 | Details |
A16007 | 28613087 | Expert Rev Gastroenterol Hepatol | An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia. | 2017 | Details |
A16008 | 28612749 | Ann Hepatol | Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance? | 2018 | Details |
A16009 | 28612634 | Expert Rev Gastroenterol Hepatol | Lysosomal acid lipase deficiency: a form of non-obese fatty liver disease (NOFLD). | 2017 | Details |
A16010 | 28612550 | Sichuan Da Xue Xue Bao Yi Xue Ban | [Serum Wnt5a and Its Associations with Liver Steatosis and Fibrosis in Overweight and Obese People]. | 2017 | Details |
A16011 | 28612527 | Sichuan Da Xue Xue Bao Yi Xue Ban | [The Effect of p-JAK1/p-STAT3 Signaling Way in Intervening NAFLD by Blueberry Probiotic Serum]. | 2017 | Details |
A16012 | 28612285 | J Endocrinol Invest | Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. | 2017 | Details |
A16013 | 28611510 | World J Gastroenterol | Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives. | 2017 | Details |
A16015 | 28611297 | Oncotarget | Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis. | 2017 | Details |
A16016 | 28611274 | Ann Hepatol | Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis. | 2018 | Details |
A16017 | 28609252 | Gut Microbes | Fecal microbiota transplantation in metabolic syndrome: History, present and future. | 2017 | Details |
A16018 | 28608850 | Nat Commun | Cellular senescence drives age-dependent hepatic steatosis. | 2017 | Details |
A16019 | 28608557 | J Food Sci | Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet. | 2017 | Details |
A16020 | 28607535 | Mediators Inflamm | Gender Disparity in the Relationship between Prevalence of Thyroid Nodules and Metabolic Syndrome Components: The SHDC-CDPC Community-Based Study. | 2017 | Details |
A16021 | 28606575 | Nutrition | Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study. | 2017 | Details |
A16022 | 28606220 | Nutr Res Rev | Current and future strategies for the nutritional management of cardiometabolic complications of androgen deprivation therapy for prostate cancer. | 2017 | Details |
A16023 | 28605664 | J Nutr Biochem | Soy compared with milk protein in a Western diet changes fecal microbiota and decreases hepatic steatosis in obese OLETF rats. | 2017 | Details |
A16024 | 28605159 | Obesity (Silver Spring) | Differential Impact of Weight Loss on Nonalcoholic Fatty Liver Resolution in a North American Cohort with Obesity. | 2017 | Details |
A16025 | 28604704 | Nat Med | Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling. | 2017 | Details |
A16026 | 28603092 | Hepatobiliary Pancreat Dis Int | Crosstalk of liver immune cells and cell death mechanisms in different murine models of liver injury and its clinical relevance. | 2017 | Details |
A16027 | 28602867 | J Ethnopharmacol | Effect of Gangjihwan on hepatic steatosis and inflammation in high fat diet-fed mice. | 2017 | Details |
A16030 | 28600319 | Physiol Genomics | Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification. | 2017 | Details |
A16031 | 28600126 | Exp Mol Pathol | Chemokine (CC-motif) receptor-like 2 mRNA is expressed in hepatic stellate cells and is positively associated with characteristics of non-alcoholic steatohepatitis in mice and men. | 2017 | Details |
A16032 | 28600116 | Surg Obes Relat Dis | Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy. | 2017 | Details |
A16033 | 28599248 | Biomed Pharmacother | The multifaceted role of natriuretic peptides in metabolic syndrome. | 2017 | Details |
A16034 | 28598982 | PLoS One | α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2. | 2017 | Details |
A16035 | 28598780 | Clin Exp Rheumatol | The liver in familial Mediterranean fever: is it involved? | 2017 | Details |
A16036 | 28598410 | Children (Basel) | Pediatric Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
A16037 | 28598045 | J Assoc Physicians India | Soft Drinks Consumption and the Risk of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
A16038 | 28597683 | Rev Esp Enferm Dig | Recurrent hyperammonemic encephalopathy. Embolization of the portosystemic shunt. | 2017 | Details |
A16039 | 28596817 | World J Hepatol | Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do. | 2017 | Details |
A16040 | 28596784 | Front Genet | INDY-A New Link to Metabolic Regulation in Animals and Humans. | 2017 | Details |
A16041 | 28596677 | World J Gastroenterol | Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease. | 2017 | Details |
A16042 | 28596431 | Eur Respir J | Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease. | 2017 | Details |
A16045 | 28595552 | Curr Med Chem | Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications. | 2018 | Details |
A16046 | 28595185 | Ann Nutr Metab | Association of Blood Fatty Acid Composition and Dietary Pattern with the Risk of Non-Alcoholic Fatty Liver Disease in Patients Who Underwent Cholecystectomy. | 2017 | Details |
A16047 | 28595079 | Int Immunopharmacol | Curcumin reduces the risk of chronic kidney damage in mice with nonalcoholic steatohepatitis by modulating endoplasmic reticulum stress and MAPK signaling. | 2017 | Details |
A16048 | 28594920 | PLoS One | Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART). | 2017 | Details |
A16049 | 28594915 | PLoS One | Conophylline inhibits non-alcoholic steatohepatitis in mice. | 2017 | Details |
A16050 | 28593786 | Rev Esp Enferm Dig | Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome. | 2017 | Details |
A16051 | 28593739 | Hepatol Res | Systematic review and meta-analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non-alcoholic fatty liver disease. | 2017 | Details |
A16052 | 28593701 | Hepatol Res | Comparison of efficacy of low-carbohydrate and low-fat diet education programs in non-alcoholic fatty liver disease: A randomized controlled study. | 2017 | Details |
A16053 | 28593184 | Cell Mol Gastroenterol Hepatol | Epigenetics and Liver Fibrosis. | 2017 | Details |
A16054 | 28592311 | Trials | The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial. | 2017 | Details |
A16055 | 28591717 | Oncotarget | Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet. | 2017 | Details |
A16056 | 28591572 | Cell Rep | Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans. | 2017 | Details |
A16057 | 28591070 | J Clin Gastroenterol | Emerging Gastrointestinal and Liver Diseases in Asia Pacific: Implications to Health Care in the Region (World Gastroenterology Organization: Asian Pacific Association of Gastroenterology Distinguished Global Lecture 2015). | 2017 | Details |
A16058 | 28590542 | Liver Transpl | The donor risk index: A decade of experience. | 2017 | Details |
A16060 | 28589339 | J Gastroenterol | A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis. | 2017 | Details |
A16061 | 28587303 | Children (Basel) | The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
A16062 | 28587208 | Mar Drugs | Xyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models. | 2017 | Details |